Renovaro Biosciences (RENB) Announces $10M in Equity Committed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024 9:06 AM EDTLOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the Company) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 percent warrant coverage.
We appreciate confidence in the Company demonstrated by the investors, said the Hon. Mark Dybul, MD, CEO. We believe this is only the beginning. We are hopeful to be able to... More
